Evicenter
MarkdownMedical informationP&T meetings
Palazestrant (OP-1250)

Previously treated ER-positive HER2-negative advanced or metastatic breast cancer

Manufacturer
Olema Oncology
Last updated
256 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Previously treated ER-positive HER2-negative advanced or metastatic breast cancer

Humanistic burden and health-related quality of life

13 evidence topics · 13 sources

Pain and EQ-5D-3L utility by metastatic site and pain severity in 739 participants in the United States and Europe